How can maternal factors influence prenatal CHD risk?

Prepare for the Fetal Echocardiography Test. Utilize flashcards and multiple-choice questions that come with hints and explanations. Ace your exam preparation!

Multiple Choice

How can maternal factors influence prenatal CHD risk?

The risk of congenital heart defects is shaped by the environment the fetus experiences during early heart formation, when the heart is developing most rapidly in the first trimester. Maternal factors can influence this process in several ways. Maternal diabetes, especially when blood sugar is poorly controlled around conception and early pregnancy, raises the chance of CHD in the baby. High glucose levels create a stressful fetal environment and disrupt normal developmental signaling, so achieving good glycemic control before and during early pregnancy helps reduce this risk. Teratogen exposure during the first weeks of gestation can directly disturb heart development. Certain medications and substances are known to increase CHD risk if taken during organ formation, so avoiding or carefully managing these exposures around conception is important. Infections during early pregnancy can also affect heart development. Some maternal infections or immune responses can alter fetal cardiac formation, leading to defects. Putting these together, the statement that maternal diabetes with poor glycemic control, teratogen exposure, and infections are associated with increased CHD risk—and that good glycemic control mitigates that risk—best captures how maternal factors influence prenatal CHD risk.

The risk of congenital heart defects is shaped by the environment the fetus experiences during early heart formation, when the heart is developing most rapidly in the first trimester. Maternal factors can influence this process in several ways.

Maternal diabetes, especially when blood sugar is poorly controlled around conception and early pregnancy, raises the chance of CHD in the baby. High glucose levels create a stressful fetal environment and disrupt normal developmental signaling, so achieving good glycemic control before and during early pregnancy helps reduce this risk.

Teratogen exposure during the first weeks of gestation can directly disturb heart development. Certain medications and substances are known to increase CHD risk if taken during organ formation, so avoiding or carefully managing these exposures around conception is important.

Infections during early pregnancy can also affect heart development. Some maternal infections or immune responses can alter fetal cardiac formation, leading to defects.

Putting these together, the statement that maternal diabetes with poor glycemic control, teratogen exposure, and infections are associated with increased CHD risk—and that good glycemic control mitigates that risk—best captures how maternal factors influence prenatal CHD risk.

More practice questions